F4/80 Monoclonal Antibody (CI:A3-1)

The University of Virginia awarded a contract to Life Technologies Corporation on June 25, 2026, for the procurement of laboratory reagents and biologics. The contract, identified as A207_PO-0452646, covers the supply of F4/80 Monoclonal Antibody (CI:A3-1), a research-grade immunological reagent commonly utilized in flow cytometry and immunohistochemical applications. The cumulative contract value is $514.00, reflecting a single line item purchase with a unit price of $514.50. The materials are designated for delivery to Xiaoliang Wang at the University of Virginia in Virginia.

This procurement represents a straightforward purchase order for biological research materials to support the institution's scientific research operations. The contract award demonstrates Life Technologies Corporation's continued role as a supplier of specialized life science products to academic research institutions within the Commonwealth of Virginia. No specific performance period beyond the award date of June 25, 2026, is documented in the available materials.